| NCT Number | NCT06501079 |
| Lead Sponsor | National Cancer Institute, Egypt |
| Conditions | Renal Neoplasm |
| Enrollment | 78 participants |
| Start Date | 2024-05-01 |
| Primary Completion | 2024-11-01 (estimated) |
| Study Completion | 2024-12-01 (estimated) |
| Updated on ClinicalTrials.gov | 2024-07-15 |